Dermatology · Hutchinson, KS
NPI
1609847243
Since 2006
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
2101 N Waldron St
Hutchinson, KS, 67502
Phone (620) 669-2500
Groups this clinician bills Medicare through
Medicare paid, 2024
$398K
11,325 services
Medicare patients, 2024
1,944
Average age 76
Drug cost, 2024
$490K
1,995 prescriptions
Company payments, 2024
$1,660
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Stephen Marshall was code 17003 (destruction skin lesion), 3,932 times for 720 patients. In total Stephen Marshall billed 11,325 services in 49 codes, and Medicare paid $398K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-08-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 3,932 | 720 | $4.48 | $18K |
| 99213 Office E&M - Established | Office | 2,533 | 1,623 | $56.39 | $143K |
| 17000 Destruction Skin Lesion | Office | 1,287 | 916 | $31.61 | $41K |
| 17110 Destruction Skin Lesion | Office | 1,123 | 928 | $67.66 | $76K |
| 88305 Surgical Pathology Examination | Office | 696 | 465 | $23.44 | $16K |
| 99202 Office E&M - New | Office | 324 | 324 | $40.78 | $13K |
| 11102 Skin Biopsy | Office | 208 | 200 | $51.75 | $11K |
| 17281 Destruction Skin Lesion | Office | 203 | 166 | $117.39 | $24K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 179 | 38 | $0.71 | $126 |
| 17280 Destruction Skin Lesion | Office | 150 | 120 | $78.96 | $12K |
| 17261 Destruction Skin Lesion | Office | 91 | 81 | $84.70 | $7,707 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 85 | 76 | $11.63 | $988 |
| 11200 Removal or Shaving of Skin Growth | Office | 77 | 76 | $47.64 | $3,669 |
| 17271 Destruction Skin Lesion | Office | 71 | 61 | $103.52 | $7,350 |
| 11900 Skin | Office | 36 | 16 | $33.66 | $1,212 |
By year: 2022 $406K for 10,595 services; 2023 $402K for 10,432 services; 2024 $398K for 11,325 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88305 Surgical Pathology Examination | 696 | 465 | $23.44 | $16K |
Medicare prescription drug claims, 2024
In 2024, the drug Stephen Marshall prescribed most often to Medicare patients was Betamethasone Valerate, with 308 prescriptions and refills. In total Stephen Marshall wrote 1,995 Medicare prescriptions that cost $490K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Betamethasone Valerate Generic | 308 | 313 | 192 | $6,054 |
| Spironolactone Generic | 252 | 420 | 48 | $2,527 |
| Minocycline Hcl Generic | 169 | 198 | 45 | $3,247 |
| Triamcinolone Acetonide Generic | 150 | 181 | 110 | $2,550 |
| Methotrexate Methotrexate Sodium | 122 | 167 | 21 | $1,770 |
| Ketoconazole Generic | 107 | 115 | 63 | $1,533 |
| Prednisone Generic | 90 | 102 | 64 | $185 |
| Hydrocortisone Generic | 80 | 86 | 58 | $1,395 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 73 | 77 | 24 | $610 |
| Cephalexin Generic | 58 | 72 | 32 | $456 |
| Acitretin Generic | 56 | 65 | Under 11 | $31K |
| Clobetasol Propionate Generic | 43 | 49 | 23 | $2,454 |
| Terbinafine Hcl Generic | 37 | 73 | 23 | $467 |
| Glycopyrrolate Generic | 36 | 44 | Under 11 | $721 |
| Doxycycline Hyclate Generic | 31 | 41 | Under 11 | $1,594 |
Brand drugs: 372 claims; generic drugs: 1,623 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Stephen Marshall $1,660 ($1,660 in general payments such as food, travel and fees) from 16 companies. The largest payer was Abbvie Inc. with $435.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 29 | $435 |
| E.R. Squibb & Sons, L.L.C. BMY | 14 | $216 |
| Amgen Inc. AMGN | 11 | $212 |
| Novartis Pharmaceuticals Corporation NVS | 10 | $192 |
| Janssen Biotech, Inc. JNJ | 5 | $104 |
| Lilly USA, LLC LLY | 5 | $79.89 |
| Regeneron Healthcare Solutions, Inc. REGN | 3 | $68.98 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 3 | $65.47 |
| UCB, Inc. UCB.BR | 3 | $64.82 |
| ConvaTec Inc. CTEC.L | 2 | $49.72 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.